Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL

Summary

a multicenter, double-blind, placebo-controlled study in patients with Sudden Sensorineural Hearing Loss (SSHL). Patients will be treated with STR001 thermogel (STR001-IT) / STR001 tablets (STR001-ER) and corresponding Placebo on top of standard of care.

Timeline

Start

2018-02-24

Primary completion

2020-02-06

Completion

2020-02-06

Drugs

Indications